Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Walldius

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|October 6, 2009
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Heart, Lung & Circulation|January 19, 2021
Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS CohortTorbjörn Ivert, Niklas Hammar, Mats Talbäck, et al.
Cancer Causes & Control : CCC|June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancerMats Lambe, Annette Wigertz, Hans Garmo, et al.
Plos One|October 30, 2014
Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohortHåkan Malmström, Göran Walldius, Valdemar Grill, et al.
Plos Medicine|August 11, 2022
Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort studyMozhu Ding, Alexandra Wennberg, Bruna Gigante, et al.
Annals of Medicine|May 27, 2011
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general populationMartin J Holzmann, Are Aastveit, Niklas Hammar, et al.
Cardiovascular Diabetology|November 25, 2021
Impaired fasting glucose: a risk factor for atrial fibrillation and heart failureViktor Lind, Niklas Hammar, Pia Lundman, et al.
Annals of Neurology|October 12, 2019
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-upSolmaz Yazdani, Daniela Mariosa, Niklas Hammar, et al.
Circulation Research|August 7, 2019
Lipids, Apolipoproteins, and the Risk of Parkinson DiseaseFang Fang, Yiqiang Zhan, Niklas Hammar, et al.
Alimentary Pharmacology & Therapeutics|December 25, 2022
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkersHannes Hagström, Jacinth Yan, Mats Talbäck, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|October 6, 2009
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)Ingar Holme, Are H Aastveit, Niklas Hammar, et al.
Heart, Lung & Circulation|January 19, 2021
Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS CohortTorbjörn Ivert, Niklas Hammar, Mats Talbäck, et al.
Cancer Causes & Control : CCC|June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancerMats Lambe, Annette Wigertz, Hans Garmo, et al.
Plos One|October 30, 2014
Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohortHåkan Malmström, Göran Walldius, Valdemar Grill, et al.
Plos Medicine|August 11, 2022
Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort studyMozhu Ding, Alexandra Wennberg, Bruna Gigante, et al.
Annals of Medicine|May 27, 2011
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general populationMartin J Holzmann, Are Aastveit, Niklas Hammar, et al.
Cardiovascular Diabetology|November 25, 2021
Impaired fasting glucose: a risk factor for atrial fibrillation and heart failureViktor Lind, Niklas Hammar, Pia Lundman, et al.
Annals of Neurology|October 12, 2019
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-upSolmaz Yazdani, Daniela Mariosa, Niklas Hammar, et al.
Circulation Research|August 7, 2019
Lipids, Apolipoproteins, and the Risk of Parkinson DiseaseFang Fang, Yiqiang Zhan, Niklas Hammar, et al.
Alimentary Pharmacology & Therapeutics|December 25, 2022
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkersHannes Hagström, Jacinth Yan, Mats Talbäck, et al.
Pageof 8